Dr Claire Kydonaki C.Kydonaki@napier.ac.uk
Visiting Lecturer
Alpha 2 Agonists for Sedation to produce Better Outcomes from Critical Illness (A2B TRIAL): A Parallel Group Randomised Controlled Trial Comparing Clonidine, Dexmedetomidine and Current Usual Care
People Involved
Project Description
This is a prospective three-arm randomised placebo-controlled trial to compare the effect of the early addition of dexmedetomidine or clonidine to current analgo-sedation practice on the duration of mechanical ventilation, compared with current analgo-sed
| Project Acronym | A2B trial |
|---|---|
| Status | Project Complete |
| Funder(s) | National Institute for Health Research |
| Value | £5,054.00 |
| Project Dates | Apr 1, 2018 - Dec 31, 2021 |
You might also like
Can counselling help patients and families after Intensive Care: a pilot study and evaluation: the CONNECT study Jan 16, 2017 - Jul 15, 2017
Surviving critical illness is associated with chronic psychological distress. Anxiety occurs in 43% of patients and depression in 30% of patients at 12 months after hospital discharge. Post-traumatic stress (e.g. distressing flashbacks) occurs in 51%...
Read More about Can counselling help patients and families after Intensive Care: a pilot study and evaluation: the CONNECT study.